HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH).

AbstractBACKGROUND:
ACTH-independent macronodular adrenal hyperplasia (AIMAH) is a rare cause of Cushing's syndrome. Bilateral adrenalectomy is considered the treatment of choice, with subsequent lifetime steroid replacement, but unilateral adrenalectomy has been recently proposed to reduce the secreting tissue. This prospective study was designed to evaluate the long-term results of unilateral adrenalectomy in AIMAH concerning the main laboratory and clinical abnormalities and the patient's quality of life.
METHODS:
Seven consecutive patients with confirmed AIMAH underwent unilateral adrenalectomy of the largest gland. ACTH and cortisol levels, arterial blood pressure (BP), glycometabolic parameters, and patient's subjective perception of health-related quality of life (by the SF-36 questionnaire) were measured preoperatively and postoperatively.
RESULTS:
No surgery-related morbidity occurred. One patient with a large contralateral adrenal enlargement required a completion adrenalectomy after 7 months because of persistent hypercortisolism. At a median follow-up of 53 (range, 27-68) months, the remaining six patients were cured, because serum and urinary free cortisol levels significantly decreased and ACTH increased, thus regaining the normal range. Both systolic and diastolic BP levels significantly reduced: 50% of patients definitively became normotensive, and the remaining patients reduced the need for antihypertensive treatment; 40% of patients suffering from preoperative diabetes were cured, whereas 40% reduced the need for hypoglycemizing drug. SF-36 evaluation of the health-related quality of life confirmed a significant amelioration.
CONCLUSIONS:
Unilateral adrenalectomy of the largest gland can be an effective and safe treatment for AIMAH in case of asymmetric involvement. It may achieve long-term remission of Cushing's syndrome and improve BP values, glycemic control, and patient's quality of life.
AuthorsMaurizio Iacobone, Nora Albiger, Carla Scaroni, Franco Mantero, Ambrogio Fassina, Giovanni Viel, Mauro Frego, Gennaro Favia
JournalWorld journal of surgery (World J Surg) Vol. 32 Issue 5 Pg. 882-9 (May 2008) ISSN: 0364-2313 [Print] United States
PMID18214589 (Publication Type: Journal Article)
Chemical References
  • Adrenocorticotropic Hormone
  • Hydrocortisone
Topics
  • Adrenal Glands (pathology)
  • Adrenalectomy
  • Adrenocorticotropic Hormone (blood)
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Hydrocortisone (blood)
  • Hyperplasia (blood, diagnosis, surgery)
  • Male
  • Middle Aged
  • Prospective Studies
  • Quality of Life
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: